Clinical Trials
Cape Fear Retina is proud to serve the coastal Carolina communities by bringing national FDA-approved clinical trials to our patients.
ACTIVE CLINICAL TRIALS
We are working to bring you information on our next Clinical Trial opportunities.
If you are interested in participation in one of our clinical trials, please talk to your physician at your next appointment.

COMING SOON!
MACULAR DEGENERATION

LUGANO
MACULAR DEGENERATION
A 2-year Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Wet AMD.
COMPLETED CLINICAL TRIALS
Clinical Trial Leadership Team
Principal Investigator
Meredith Triplett
Clinical Research Coordinator